Elanco Animal Health Incorporated

ELAN ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018
Assets
Cash & Equivalents $545.0M $468.0M $352.0M $345.0M $638.0M $495.0M $334.0M $474.8M
Accounts Receivable $873.0M $805.0M $842.0M $797.0M $833.0M $872.0M $816.9M $651.8M
Inventory $1.74B $1.57B $1.74B $1.54B $1.37B $1.58B $1.05B $1.00B
Total Current Assets $3.46B $3.22B $3.41B $3.28B $3.27B $3.42B $2.37B $2.50B
Property, Plant & Equipment — $993.0M $1.03B $999.0M $1.06B $1.32B $955.3M $922.4M
Goodwill $4.78B $4.41B $5.09B $5.99B $6.17B $6.23B $2.99B $2.96B
Intangible Assets (Excl. Goodwill) $3.41B $3.68B $4.49B $4.84B $5.59B $6.39B $2.48B $2.50B
Total Assets $13.36B $12.61B $14.36B $15.49B $16.48B $17.69B $8.99B $8.96B
Liabilities
Accounts Payable $368.0M $296.0M $270.0M $390.0M $416.0M $501.0M $222.6M $205.2M
Total Current Liabilities $1.60B $1.32B $1.24B $1.70B $1.65B $2.08B $818.5M $970.7M
Long-Term Debt $3.76B $4.28B $5.74B $5.45B $6.03B $5.57B $2.33B $2.44B
Total Liabilities $6.81B $6.52B $8.14B $8.20B $8.97B $9.22B $3.44B $3.76B
Stockholders' Equity
Retained Earnings $-2.18B $-1.95B $-2.29B $-1.06B $-979.0M $-477.0M $84.3M $16.4M
Total Stockholders' Equity $6.55B $6.10B $6.22B $7.29B $7.51B $8.46B $5.54B $5.20B
← Newer Page 1 of 2 Older →